Clinical Heterogeneity of Neuronal Ceroid Lipofuscinosis Type 13: A Case Report and Systematic Review of Literature.

IF 3.7 3区 医学 Q2 CLINICAL NEUROLOGY Neurology-Genetics Pub Date : 2024-12-23 eCollection Date: 2025-02-01 DOI:10.1212/NXG.0000000000200227
Nikhil B Ghayal, Shanu F Roemer, Philip W Tipton, Peizhou Jiang, Elizabeth M Selner, Dawn S Peck, Aya Murakami, Devin Oglesbee, Neill R Graff-Radford, Dennis W Dickson
{"title":"Clinical Heterogeneity of Neuronal Ceroid Lipofuscinosis Type 13: A Case Report and Systematic Review of Literature.","authors":"Nikhil B Ghayal, Shanu F Roemer, Philip W Tipton, Peizhou Jiang, Elizabeth M Selner, Dawn S Peck, Aya Murakami, Devin Oglesbee, Neill R Graff-Radford, Dennis W Dickson","doi":"10.1212/NXG.0000000000200227","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>In this study, we describe a 54-year-old Indian woman who presented with clinical features of Kufs syndrome A (KSA) and Kufs syndrome B (KSB), as well as neuropathologic and genetic findings consistent with neuronal ceroid lipofuscinosis type 13 (CLN13). Subsequently, we review the clinicopathologic features of 20 patients with CLN13 reported in the literature.</p><p><strong>Methods: </strong>Data and imaging were obtained from the patient's medical records. The patient was examined neuropathologically, and next-generation sequencing was performed.</p><p><strong>Results: </strong>Clinical radiologic scans revealed bilateral cortical atrophy, ventriculomegaly, a thin corpus callosum, and cerebellar vermian atrophy. Pathologic examination was remarkable for NCL. Postmortem genetic testing revealed a homozygous <i>cathepsin F</i> (<i>CTSF</i>) indel variant. A review of 20 reported CLN13 patients revealed novel clinical subtypes, including KSB type I (KSB-I), KSB type II (KSB-II), and Kufs syndrome C (KSC).</p><p><strong>Discussion: </strong>CLN13 was clinically heterogeneous. Most patients with CLN13 (14/20) did not present with classic KSB (KSB-I). Instead, 6 patients presented with KSB-II, 4 patients presented with KSC (including the present patient), and 3 patients presented with dementia. Our results expand the CLN13 clinical spectrum and emphasize the importance of screening <i>CTSF</i> variants in clinical dementia and movement disorder cohorts.</p>","PeriodicalId":48613,"journal":{"name":"Neurology-Genetics","volume":"11 1","pages":"e200227"},"PeriodicalIF":3.7000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11668517/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology-Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXG.0000000000200227","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: In this study, we describe a 54-year-old Indian woman who presented with clinical features of Kufs syndrome A (KSA) and Kufs syndrome B (KSB), as well as neuropathologic and genetic findings consistent with neuronal ceroid lipofuscinosis type 13 (CLN13). Subsequently, we review the clinicopathologic features of 20 patients with CLN13 reported in the literature.

Methods: Data and imaging were obtained from the patient's medical records. The patient was examined neuropathologically, and next-generation sequencing was performed.

Results: Clinical radiologic scans revealed bilateral cortical atrophy, ventriculomegaly, a thin corpus callosum, and cerebellar vermian atrophy. Pathologic examination was remarkable for NCL. Postmortem genetic testing revealed a homozygous cathepsin F (CTSF) indel variant. A review of 20 reported CLN13 patients revealed novel clinical subtypes, including KSB type I (KSB-I), KSB type II (KSB-II), and Kufs syndrome C (KSC).

Discussion: CLN13 was clinically heterogeneous. Most patients with CLN13 (14/20) did not present with classic KSB (KSB-I). Instead, 6 patients presented with KSB-II, 4 patients presented with KSC (including the present patient), and 3 patients presented with dementia. Our results expand the CLN13 clinical spectrum and emphasize the importance of screening CTSF variants in clinical dementia and movement disorder cohorts.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
13型神经性脑蜡样脂褐质病的临床异质性:1例报告及文献综述。
目的:在这项研究中,我们描述了一名54岁的印度女性,她表现出库夫斯综合征a (KSA)和库夫斯综合征B (KSB)的临床特征,以及神经病理学和遗传学结果与13型神经性神经蜡样脂褐质病(CLN13)一致。随后,我们回顾了文献中报道的20例CLN13患者的临床病理特征。方法:从患者病历中获取资料和影像。对患者进行神经病理学检查,并进行下一代测序。结果:临床放射学扫描显示双侧皮质萎缩,脑室肿大,胼胝体薄,小脑蚓萎缩。NCL病理检查结果显著。死后基因检测显示一个纯合子组织蛋白酶F (CTSF) indel变体。对20例已报道的CLN13患者的回顾揭示了新的临床亚型,包括KSB I型(KSB-I), KSB II型(KSB-II)和库夫斯综合征C (KSC)。讨论:CLN13具有临床异质性。大多数CLN13患者(14/20)不表现为经典KSB (KSB- i)。相反,6例患者表现为KSB-II, 4例患者表现为KSC(包括本患者),3例患者表现为痴呆。我们的研究结果扩大了CLN13的临床谱,并强调了在临床痴呆和运动障碍队列中筛查CTSF变异的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurology-Genetics
Neurology-Genetics Medicine-Neurology (clinical)
CiteScore
6.30
自引率
3.20%
发文量
107
审稿时长
15 weeks
期刊介绍: Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.
期刊最新文献
Novel VRK1 Variants and a Founder Effect in Axonal Polyneuropathy. KCNQ2 Variants in Neonatal Epilepsy: Clinical Characteristics and Neurodevelopmental Outcomes in 30 Patients. Prognostic Significance of NOTCH3 Small Vessel Disease Staging for the NOTCH3 p.R544C Variant. Parkinson Disease Pathogenic Variants: Cross-Ancestry Analysis and Microarray Data Validation. Neurogenetics and Neurology® Genetics: Worlds Ever-Expanding.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1